Senior Principal Scientist, Clinical Pharmacology
Genentech, Inc.
South San Francisco, California
Katie Maass is a Senior Principal Scientist in the Clinical Pharmacology Department at Genentech. She has focused on ophthalmology projects since joining Genentech in January 2016. Katie has experience on drug development teams at stages from pre-IND through post approval and has contributed to cross-functional teams on clinical development plans, protocols, regulatory interactions and submissions, quantitative PK/PD data analysis, and modeling & simulation. Before joining Genentech, Katie was a graduate student in chemical engineering at Massachusetts Institute of Technology (MIT), where she completed her PhD studying the cellular level processing of antibody-drug conjugates.
Disclosure information not submitted.
Wednesday, May 15, 2024
11:30 AM – 12:30 PM PT